Please find a selection of featured BIA publications below. To see our full publications library, click here.
This guide explains how the Patent Box regime works and what bioscience companies should consider when choosing if and when to elect into it.
An overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders from October 2017 to January 2018.
A new report released by the BioIndustry Association (BIA) and Informa Pharma Intelligence reveals that the UK has the strongest clinical and preclinical pipeline in Europe.
Ensuring investors and the wider public are well informed and confident about bioscience is crucial to the success of individual companies and the sector as a whole. To support the sector to maintain high standards in communications about R&D progress, the BIA has produced a best practice guide for bioscience companies with a supporting library of resources.